Looking inside ourselves and out at the world
Independent and neutral with regard to all political and religious orientations,® aims to promote awareness of the major democratic principles on which tolerance is based.

Pfizer R&D Head Presses Case For AstraZeneca Deal

Pfizer's research head pressed the case for combining with AstraZeneca on Monday in the latest stage of a campaign by the U.S. drugmaker to counter critics of its proposed $106 billion deal. Mikael Dolsten said he had been through five different mergers and acquisitions and denied such big transactions disrupted drug research. And that's, of course, true for Pfizer scientists and AZ scientists and will be true also if we can make a potential combination come together.

© DailyMotion -

Comment on this article!
To post a comment, we encourage you to become a member of® or log in if you are already a member. You can still post your commentwithout registering, but you will need to fill your personal information each time.

Become a member (free)   |   Log in

Postings are subject to the terms and conditions of®. Before submitting your message , you must read the Terms and conditions of® and agree to them by checking the box below.
Your name:
  I have read and agree to the Terms and conditions of®.
Follow us on ...
Facebook Twitter